|
1
|
Azamjah N, Soltan-Zadeh Y and Zayeri F:
Global trend of breast cancer mortality rate: A 25-year study.
Asian Pac J Cancer Prev. 20:2015–2020. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li M, Marin-Muller C, Bharadwaj U, Chow
KH, Yao QZ and Chen CY: MicroRNAs: Control and loss of control in
human physiology and disease. World J Surg. 33:667–684. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oliveto S, Mancino M, Manfrini N and Biffo
S: Role of microRNAs in translation regulation and cancer. World J
Biol Chem. 8:45–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Silber J, Lim DA, Petritsch C, Persson AI,
Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello
JF, et al: miR-124 and miR-137 inhibit proliferation of
glioblastoma multiforme cells and induce differentiation of brain
tumor stem cells. BMC Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen J, Xiao H, Huang Z, Hu Z, Qi T, Zhang
B, Tao X and Liu SH: MicroRNA124 regulate cell growth of prostate
cancer cells by targeting iASPP. Int J Clin Exp Pathol.
7:2283–2290. 2014.PubMed/NCBI
|
|
6
|
Hu CB, Li QL, Hu JF, Zhang Q, Xie JP and
Deng L: miR-124 inhibits growth and invasion of gastric cancer by
targeting ROCK1. Asian Pac J Cancer Prev. 15:6543–6546. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma T, Zhao Y, Wei K, Yao G, Pan C, Liu B,
Xia Y, He Z, Qi X, Li Z, et al: MicroRNA-124 functions as a tumor
suppressor by regulating CDH2 and epithelial-mesenchymal transition
in non-small cell lung cancer. Cell Physiol Biochem. 38:1563–1574.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi P, Chen C, Li X, Wei Z, Liu Z and Liu
Y: MicroRNA124 suppresses cell proliferation and invasion of triple
negative breast cancer cells by targeting STAT3. Mol Med Rep.
19:3667–3675. 2019.PubMed/NCBI
|
|
9
|
Ji H, Sang M, Liu F, Ai N and Geng C:
miR-124 regulates EMT based on ZEB2 target to inhibit invasion and
metastasis in triple-negative breast cancer. Pathol Res Pract.
215:697–704. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji
Y, Wang J, Zhao H and Han ZC: MicroRNA-124 suppresses breast cancer
cell growth and motility by targeting CD151. Cell Physiol Biochem.
31:823–832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan G, Li Y, Zhan L, Sun S, Yuan J, Wang
T, Yin Y, Dai Z, Zhu Y, Jiang Z, et al: Decreased miR-124-3p
promoted breast cancer proliferation and metastasis by targeting
MGAT5. Am J Cancer Res. 9:585–596. 2019.PubMed/NCBI
|
|
12
|
Du S, Li H, Sun X, Li D, Yang Y, Tao Z, Li
Q and Liu K: MicroRNA-124 inhibits cell proliferation and migration
by regulating SNAI2 in breast cancer. Oncol Rep. 36:3259–3266.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Chen L, Wu Z, Wang M, Jin F, Wang
N, Hu X, Liu Z, Zhang CY, Zen K, et al: miR-124-3p functions as a
tumor suppressor in breast cancer by targeting CBL. BMC Cancer.
16:8262016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng T, Xu D, Tu C, Li W, Ning Y, Ding J,
Wang S, Yuan L, Xu N, Qian K, et al: miR-124 inhibits cell
proliferation in breast cancer through downregulation of CDK4.
Tumour Biol. 36:5987–5997. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li L, Luo J, Wang B, Wang D, Xie X, Yuan
L, Guo J, Xi S, Gao J, Lin X, et al: Microrna-124 targets
flotillin-1 to regulate proliferation and migration in breast
cancer. Mol Cancer. 12:1632013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li W, Zang W, Liu P, Wang Y, Du Y, Chen X,
Deng M, Sun W, Wang L, Zhao G and Zhai B: MicroRNA-124 inhibits
cellular proliferation and invasion by targeting Ets-1 in breast
cancer. Tumour Biol. 35:10897–10904. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai WL, Huang WD, Li B, Chen TR, Li ZX,
Zhao CL, Li HY, Wu YM, Yan WJ and Xiao JR: microRNA-124 inhibits
bone metastasis of breast cancer by repressing Interleukin-11. Mol
Cancer. 17:92018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Trapnell C, Roberts A, Goff L, Pertea G,
Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL and Pachter L:
Differential gene and transcript expression analysis of RNA-seq
experiments with TopHat and Cufflinks. Nat Protoc. 7:562–578. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Trapnell C, Williams BA, Pertea G,
Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ and Pachter
L: Transcript assembly and quantification by RNA-Seq reveals
unannotated transcripts and isoform switching during cell
differentiation. Nat Biotechnol. 28:511–515. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin J, Wen X, Zhang X, Sun X, Yunzhi L,
Peng R, Zhu M, Wang M, Zhang Y, Luo W, et al: miR-135a-5p and
miR-124-3p Inhibit Malignancy of Glioblastoma by Downregulation of
Syndecan Binding Protein. J Biomed Nanotechnol. 14:1317–1329. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee SU, Song HO, Lee W, Singaravelu G, Yu
JR and Park WY: Identification and characterization of a putative
basic helix-loop-helix (bHLH) transcription factor interacting with
calcineurin in C. elegans. Mol Cells. 28:455–461. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Liang L, Huang L, Ma X, Li D and Cai
S: High expression of protein phosphatase 4 is associated with the
aggressive malignant behavior of colorectal carcinoma. Mol Cancer.
14:952015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu X, Zhang B, Guo Y, Liang Q, Wu C, Wu
L, Tao K, Wang G and Chen J: Down-regulation of AP-4 inhibits
proliferation, induces cell cycle arrest and promotes apoptosis in
human gastric cancer cells. PLoS One. 7:e370962012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cancer Genome Atlas Network: Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang YF, Ao X, Liu Y, Ding D, Jiao WJ, Yu
Z, Zhai WX, Dong SH, He YQ, Guo H and Wang JX: MicroRNA-608
promotes apoptosis in non-small cell lung cancer cells treated with
doxorubicin through the inhibition of TFAP4. Front Genet.
10:8092019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang T, Chen QF, Chang BY, Shen LJ, Li W,
Wu PH and Fan WJ: TFAP4 promotes hepatocellular carcinoma invasion
and metastasis via activating the PI3K/AKT signaling pathway. Dis
Markers. 2019:71292142019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song J, Xie C, Jiang L, Wu G, Zhu J, Zhang
S, Tang M, Song L and Li J: Transcription factor AP-4 promotes
tumorigenic capability and activates the Wnt/β-catenin pathway in
hepatocellular carcinoma. Theranostics. 8:3571–3583. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
D'Annibale S, Kim J, Magliozzi R, Low TY,
Mohammed S, Heck AJ and Guardavaccaro D: Proteasome-dependent
degradation of transcription factor activating enhancer-binding
protein 4 (TFAP4) controls mitotic division. J Biol Chem.
289:7730–7737. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ma W, Liu B, Li J, Jiang J, Zhou R, Huang
L, Li X, He X and Zhou Q: MicroRNA-302c represses
epithelial-mesenchymal transition and metastasis by targeting
transcription factor AP-4 in colorectal cancer. Biomed
Pharmacother. 105:670–676. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shi L, Jackstadt R, Siemens H, Li H,
Kirchner T and Hermeking H: p53-induced miR-15a/16-1 and AP4 form a
double-negative feedback loop to regulate epithelial-mesenchymal
transition and metastasis in colorectal cancer. Cancer Res.
74:532–542. 2014. View Article : Google Scholar : PubMed/NCBI
|
